These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effects of second and third generation oral contraceptives and their respective progestagens on the coagulation system in the absence or presence of the factor V Leiden mutation. Kemmeren JM; Algra A; Meijers JC; Bouma BN; Grobbee DE Thromb Haemost; 2002 Feb; 87(2):199-205. PubMed ID: 11859850 [TBL] [Abstract][Full Text] [Related]
3. Cerebral venous sinus thrombosis in users of four hormonal contraceptives: levonorgestrel-containing oral contraceptives, norgestimate-containing oral contraceptives, desogestrel-containing oral contraceptives and the contraceptive patch. Jick SS; Jick H Contraception; 2006 Oct; 74(4):290-2. PubMed ID: 16982227 [TBL] [Abstract][Full Text] [Related]
4. [New forms of hormonal contraception]. Gaspard U; Buicu C; van den Brûle F J Gynecol Obstet Biol Reprod (Paris); 2000 May; 29(3):288-91. PubMed ID: 10804374 [TBL] [Abstract][Full Text] [Related]
18. What is the risk of venous thromboembolism (VTE) among women taking third-generation oral contraceptives (OCs) in comparison with those taking contraceptives containing levonorgestrel? Meurer LN; Slawson JG J Fam Pract; 2001 Feb; 50(2):108. PubMed ID: 11219554 [No Abstract] [Full Text] [Related]